Literature DB >> 31718874

Treatment of life-threatening Pseudomonas aeruginosa infection by pheresis of inhibitory antibodies.

Chandima Divithotawela1, Amy Pham2, Emma L Ledger2, Peter Hopkins3, Timothy J Wells4, Daniel Chambers3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31718874     DOI： 10.1016/j.healun.2019.10.001

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  4 in total

Review 1.  Antibody-Dependent Enhancement of Bacterial Disease: Prevalence, Mechanisms, and Treatment.

Authors:  Von Vergel L Torres; Carrie F Coggon; Timothy J Wells
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

2.  Anti-LPS IgA and IgG Can Inhibit Serum Killing of Pseudomonas aeruginosa in Patients with Cystic Fibrosis.

Authors:  Amy Pham; Emma L Ledger; Carrie F Coggon; Ian R Henderson; David W Reid; Scott C Bell; Daniel J Smith; Timothy J Wells
Journal:  Infect Immun       Date:  2021-08-30       Impact factor: 3.441

Review 3.  Molecular Mechanisms Involved in Pseudomonas aeruginosa Bacteremia.

Authors:  Stéphane Pont; Manon Janet-Maitre; Eric Faudry; François Cretin; Ina Attrée
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Can we decloak how infections drive complications after lung transplantation?

Authors:  Hrishikesh S Kulkarni; Erika D Lease
Journal:  J Heart Lung Transplant       Date:  2021-05-29       Impact factor: 13.569
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.